新辅助化疗联合全腔镜Mckeown术对中上段食管癌患者血清TGF⁃β1、鳞状细胞癌相关性抗原及远期疗效的影响

doi:10.3969/j.issn.1006⁃5725.2021.16.015

实用医学杂志 ›› 2021, Vol. 37 ›› Issue (16): 2109-2113.doi: 10.3969/j.issn.1006⁃5725.2021.16.015

新辅助化疗联合全腔镜Mckeown术对中上段食管癌患者血清TGF⁃β1、鳞状细胞癌相关性抗原及远期疗效的影响

周经月，解明华，张干

中国科技大学附属第一医院（安徽省立医院）胸外科（合肥 230001）

出版日期:2021-08-25 发布日期:2021-08-25
基金资助:
2020 年安徽省重点研究与开发计划项目（编号：202004j07020018）

Effect of neoadjuvant chemotherapy combined with total endoscopic Mckeown procedure on serum TGF⁃β1， squamous cell carcinoma ⁃ associated antigen and long ⁃ term curative effect in patients with middle and upper esophageal cancer

ZHOU Jingyue，XIE Minghua，ZHANG Gan.

Department of Thoracic Surgery，the First Affiliated Hospital of University of Science and Technology of China（Anhui Provincial Hospital），Hefei 230001， China

Online:2021-08-25 Published:2021-08-25

摘要/Abstract

摘要：

目的探究新辅助化疗联合全腔镜 Mckeown 术对中上段食管癌患者血清转化生长因子⁃β1 （TGF⁃β1）、鳞状细胞癌相关性抗原（SCC）及远期疗效的影响。方法回顾性收集于我院接受诊疗的 96 例中下段食管癌患者临床资料，根据治疗方法不同分为两组。观察组采取新辅助化疗联合全腔镜 Mckeown 术治疗，对照组采取单纯全腔镜 Mckeown 术治疗。比较两组患者 TGF⁃β1、SCC 水平，统计和分析两组患者生存质量、复发情况、生存率以及远期并发症发生情况。结果术后3个月，两组患者血清TGF⁃β1、SCC水平均显著低于术前（P＜0.05），且观察组患者血清TGF⁃β1、SCC水平显著低于对照组（P＜0.05）；术前，两组患者生存质量得分比较差异无统计学意义（P＞0.05），但术后6、9个月，观察组患者生存质量得分均显著高于对照组（P＜0.05）；观察组患者随访期间复发率以及复发时间均显著低于对照组（P＜0.05）；术后1年，两组患者生存率比较差异无统计学意义（P＞0.05）；但术后3、5年，观察组患者生存率均显著高于对照组（P＜0.05）；观察组患者远期并发症发生率与对照组比较差异无统计学意义（P＞0.05）。结论新辅助化疗联合全腔镜 Mckeown术治疗能有效降低中上段食管癌患者血清TGF⁃β1、SCC水平，远期疗效相对可靠。

关键词:

新辅助化疗, , 全腔镜Mckeown , 术, , 食管癌, , TGF?β1, , SCC , 远期疗效

Abstract:

Objective To investigate the effect of neoadjuvant chemotherapy combined with total endo⁃ scopic Mckeown procedure on serum transforming growth factor⁃β1（TGF⁃β1），squamous cell carcinoma（SCC）⁃ associated antigen and long ⁃term curative effect in patients with middle and upper esophageal cancer. Methods The clinical data of 96 patients with middle and upper esophageal cancer in the hospital were retrospectively analyzed. According to the treatment method，they were divided into two groups. Patients in the study group were treated with neoadjuvant chemotherapy and subjected to total endoscopic Mckeown procedure，while patients in the control group were subjected to total endoscopic Mckeown procedure alone. The levels of TGF ⁃ β1 and SCC in the two groups were compared，and quality of life，recurrence，survival rate and the incidence of long⁃term complications in the two groups were analyzed. Results At 3 months after operation，serum TGF⁃β1 and SCC level in the two groups were significantly lower than those before operation（P < 0.05，respectively），and serum TGF⁃β1 and SCC level in the study group were significantly lower than those in the control group（P < 0.05，respectively）. Before operation，no significant difference in quality of life scores was observed between the two groups（P > 0.05），but patients in the study group had significantly higher quality of life scores than those in the control group at 6 and 9 months after operation（P < 0.05）. The recurrence rate and recurrence time in the study group during the follow⁃up period were significantly lower and shorter than those in the control group（P < 0.05，respectively）. One year after operation，there was no significant difference in the survival rate between the two groups（P > 0.05），but the sur⁃ vival rate in the study group was significantly higher than that in the control group at 3 and 5 years after operation （P < 0.05）There was no significant difference in the incidence of long⁃term complications between the two groups（P > 0.05）. Conclusion Neoadjuvant chemotherapy combined with total endoscopic Mckeown procedure could effectively lower serum TGF⁃β1 and SCC levels in patients with middle and lower esophageal cancer.

Key words:

neoadjuvant chemotherapy, total endoscopic Mckeown procedure, esophageal cancer, TGF?β1, SCC, long?term curative effect

周经月, 解明华, 张干.

新辅助化疗联合全腔镜Mckeown术对中上段食管癌患者血清TGF⁃β1、鳞状细胞癌相关性抗原及远期疗效的影响 [J]. 实用医学杂志, 2021, 37(16): 2109-2113.

ZHOU Jingyue, XIE Minghua, ZHANG Gan..

Effect of neoadjuvant chemotherapy combined with total endoscopic Mckeown procedure on serum TGF⁃β1， squamous cell carcinoma ⁃ associated antigen and long ⁃ term curative effect in patients with middle and upper esophageal cancer [J]. The Journal of Practical Medicine, 2021, 37(16): 2109-2113.

[1]	王上增,张北,王禛,马尚,阮张德阳,殷志颖,朱云麒,胡昆鹏,程韶. CR假体与PS假体治疗膝骨性关节炎的效果比较[J]. 实用医学杂志, 2024, 40(9): 1251-1256.
[2]	崔天玥,欧阳理权,张胜初. 单纯手术与手术联合糖皮质激素治疗肿块型肉芽肿性乳腺炎的临床疗效[J]. 实用医学杂志, 2024, 40(9): 1268-1274.
[3]	崔晓荣,兰丽华,李向阳,钟志锋. 基于MSCT三维扫描加重建对成人髋关节发育不良全髋关节置换术中髋臼假体的选择及截骨的准确性预测价值[J]. 实用医学杂志, 2024, 40(9): 1309-1313.
[4]	梁鹏. 麻醉医师在日间手术全流程管理中的作用[J]. 实用医学杂志, 2024, 40(8): 1031-1037.
[5]	钱玥,马正良. 快速康复外科理念下日间手术的麻醉与围术期质量控制[J]. 实用医学杂志, 2024, 40(8): 1042-1046.
[6]	张俊杰,杨晓春,刘卓懿,吴若秋,李平,郭曲练,王锷. 基于BIS和微旁流EtCO₂监护下甲苯磺酸瑞马唑仑在日间宫腔镜手术麻醉中的有效性和安全性[J]. 实用医学杂志, 2024, 40(8): 1047-1051.
[7]	陈红芽,王惠军,王月,苏少飞,王古岩. 瑞马唑仑与丙泊酚对老年眼底日间手术患者全麻恢复质量的影响[J]. 实用医学杂志, 2024, 40(8): 1052-1057.
[8]	孙行,王敏,牛舒婕,仲艺伟,路子蕴,徐璐,杨如松,王涛,孙玉娥,马正良,李冰冰. 单孔和双孔胸腔镜肺结节日间手术对患者术后疼痛和早期预后的影响[J]. 实用医学杂志, 2024, 40(8): 1058-1062.
[9]	汤黎黎,孙月,刘学胜,陆姚. 不同性别对日间关节镜手术患者瑞马唑仑使用剂量及术后恢复质量的影响[J]. 实用医学杂志, 2024, 40(8): 1063-1068.
[10]	刘民强,洪凤珠,郭珊珊,何俊永,杨晓瑞,施琴朗,何仁亮,吴强. 无阿片保留自主呼吸麻醉在手汗症日间手术中的应用[J]. 实用医学杂志, 2024, 40(8): 1069-1073.
[11]	李开瑜,汤敏誉,梁鹏. 靶控输注舒芬太尼或瑞芬太尼对日间腹腔镜胆囊切除术患者术后镇痛和恢复的影响[J]. 实用医学杂志, 2024, 40(8): 1074-1077.
[12]	王晚霞,马红,陈瑾,程康,刘美玉. 不同剂量艾司氯胺酮复合七氟醚麻醉在小儿日间包皮手术中的应用效果观察[J]. 实用医学杂志, 2024, 40(8): 1078-1082.
[13]	王保,马树霖,尧新华,杨帆,温凯,罗思静,甘英,鲁义. 术中电针镇痛对全麻甲状腺手术患者气管插管应激反应的影响[J]. 实用医学杂志, 2024, 40(8): 1132-1136.
[14]	胡希,李艳,刘洋. 深度学习在辅助生殖技术领域的应用进展[J]. 实用医学杂志, 2024, 40(7): 893-897.
[15]	刘晓童,苏鲜花,辛志军,高奉琼,冯加义,夏同霞. 脊柱结核患者术后并发症危险因素及术前预后营养指数的预测价值[J]. 实用医学杂志, 2024, 40(7): 972-978.

新辅助化疗联合全腔镜Mckeown术对中上段食管癌患者血清TGF⁃β1、鳞状细胞癌相关性抗原及远期疗效的影响

Effect of neoadjuvant chemotherapy combined with total endoscopic Mckeown procedure on serum TGF⁃β1， squamous cell carcinoma ⁃ associated antigen and long ⁃ term curative effect in patients with middle and upper esophageal cancer

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价